• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测经皮冠状动脉介入治疗中存在预先存在的肾功能损害患者对比剂诱导肾病的风险评分系统。

Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.

机构信息

Alexandra Hospital, Jurong General Health, 378 Alexandra Road, Singapore 159964.

出版信息

Singapore Med J. 2012 Mar;53(3):164-9.

PMID:22434288
Abstract

INTRODUCTION

Baseline renal impairment is the most recognised risk factor for development of contrast-induced nephropathy (CIN) post percutaneous coronary intervention (PCI). We examined the additional risk factors in this high-risk group and aimed to develop a risk model for prediction of CIN.

METHODS

A cohort of 770 consecutive patients with existing impaired renal function (estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m2), who received routine prophylactic saline hydration and oral N-acetylcysteine treatment while undergoing PCI between May 2005 to October 2008 in our centre, were enrolled. The study endpoint, CIN, was defined as > 25% increase from baseline creatinine within 48 hours post PCI.

RESULTS

Despite routine prophylaxis, CIN occurred in 11.4% of the patients. Important clinical predictors for CIN were age (odds ratio [OR] 1.59, 95% confidence level [CI] 1.0-2.52, p = 0.049), anaemia with haemoglobin < 11 mg/dL (OR 2.26, 95% CI 1.41-3.61, p = 0.001), post-procedure creatinine kinase rise (OR 1.12, 95% CI 1.07-1.16 for every 500 u/L increase, p < 0.001), systolic hypotension with blood pressure < 100 mmHg (OR 2.53, 95% CI 1.16-5.52, p = 0.016) and higher contrast volume. The incidence of CIN was significantly higher in patients with more severe renal failure (6.3%, 17.4% and 40.8% when eGFR was 40-60, 20-40 and < 20 ml/min/1.73 m2 respectively, p < 0.001). A prediction model was developed based on these findings. The incidence of CIN could vary from 2% to > 50% depending on these additional risk profiles.

CONCLUSION

Patients with impaired renal function undergoing PCI are at high risk of developing CIN despite traditional prophylaxis. A model of risk prediction could be used to predict its occurrence.

摘要

简介

基线肾功能损害是经皮冠状动脉介入治疗(PCI)后发生对比剂肾病(CIN)的最公认的危险因素。我们检查了该高危人群中的其他危险因素,并旨在建立预测 CIN 的风险模型。

方法

我们纳入了 2005 年 5 月至 2008 年 10 月期间在我们中心接受常规预防性生理盐水水化和口服 N-乙酰半胱氨酸治疗的 770 例连续存在肾功能损害(估算肾小球滤过率(eGFR)<60 ml/min/1.73 m2)的患者。研究终点为 PCI 后 48 小时内基线肌酐升高>25%的 CIN。

结果

尽管进行了常规预防,但仍有 11.4%的患者发生 CIN。CIN 的重要临床预测因素包括年龄(优势比[OR]1.59,95%置信区间[CI]1.0-2.52,p=0.049)、血红蛋白<11mg/dL 的贫血(OR 2.26,95%CI 1.41-3.61,p=0.001)、术后肌酸激酶升高(OR 1.12,95%CI 每增加 500u/L 增加 1.07-1.16,p<0.001)、血压<100mmHg 的收缩期低血压(OR 2.53,95%CI 1.16-5.52,p=0.016)和更高的造影剂体积。肾功能衰竭更严重的患者(当 eGFR 分别为 40-60、20-40 和<20 ml/min/1.73 m2 时,CIN 的发生率分别为 6.3%、17.4%和 40.8%,p<0.001)的 CIN 发生率明显更高。基于这些发现建立了预测模型。根据这些附加风险概况,CIN 的发生率可能从 2%到>50%不等。

结论

尽管采用了传统的预防措施,接受 PCI 的肾功能损害患者发生 CIN 的风险仍然很高。风险预测模型可用于预测其发生。

相似文献

1
Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.用于预测经皮冠状动脉介入治疗中存在预先存在的肾功能损害患者对比剂诱导肾病的风险评分系统。
Singapore Med J. 2012 Mar;53(3):164-9.
2
Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions.贫血对行经皮冠状动脉介入治疗患者对比剂诱导肾病(CIN)的影响。
Int Urol Nephrol. 2013 Aug;45(4):1065-70. doi: 10.1007/s11255-012-0340-8. Epub 2012 Dec 7.
3
Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.接受经皮冠状动脉介入治疗患者中对比剂肾病的临床结局:一项分析水化和乙酰半胱氨酸作用的前瞻性、多中心、随机研究
Int J Cardiol. 2008 Jun 6;126(3):407-13. doi: 10.1016/j.ijcard.2007.05.004. Epub 2007 Jul 24.
4
Contrast-induced nephropathy in urgent coronary interventions.急诊冠状动脉介入治疗中的造影剂肾病
J Cardiovasc Med (Hagerstown). 2006 Oct;7(10):737-41. doi: 10.2459/01.JCM.0000247320.72783.1c.
5
The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.对比剂容积与肾小球滤过率的比值可预测 ST 段抬高型急性心肌梗死经皮冠状动脉介入治疗的结局。
Catheter Cardiovasc Interv. 2011 Aug 1;78(2):198-201. doi: 10.1002/ccd.22828. Epub 2010 Oct 14.
6
Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.水化联合或不联合N-乙酰半胱氨酸对接受冠状动脉造影和经皮冠状动脉介入治疗患者造影剂肾病的影响。
Mymensingh Med J. 2011 Apr;20(2):264-9.
7
Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine.血清肌酐正常的经皮冠状动脉介入治疗患者对比剂肾病的危险因素和临床转归。
Ann Acad Med Singap. 2010 May;39(5):374-80.
8
Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.年龄、肾小球滤过率、射血分数和AGEF评分可预测接受直接经皮冠状动脉介入治疗的急性心肌梗死患者的造影剂肾病。
Catheter Cardiovasc Interv. 2013 Nov 15;82(6):878-85. doi: 10.1002/ccd.25023. Epub 2013 Jun 27.
9
CHADS2 score predicts risk of contrast-induced nephropathy in stable coronary artery disease patients undergoing percutaneous coronary interventions.CHADS2评分可预测接受经皮冠状动脉介入治疗的稳定型冠状动脉疾病患者发生造影剂肾病的风险。
J Formos Med Assoc. 2016 Jul;115(7):501-9. doi: 10.1016/j.jfma.2015.12.008. Epub 2016 Jan 28.
10
Contrast induced nephropathy in patients with pre-existing renal impairment undergoing coronary angiogram and percutaneous transluminal coronary angioplasty.患有既往肾功能损害的患者在接受冠状动脉造影和经皮冠状动脉腔内血管成形术时发生的造影剂肾病。
Mymensingh Med J. 2011 Apr;20(2):270-4.

引用本文的文献

1
Endorsement of the TRIPOD statement and the reporting of studies developing contrast-induced nephropathy prediction models for the coronary angiography/percutaneous coronary intervention population: a cross-sectional study.支持 TRIPOD 声明和报告用于冠状动脉造影/经皮冠状动脉介入人群的对比剂肾病预测模型研究:一项横断面研究。
BMJ Open. 2022 Feb 21;12(2):e052568. doi: 10.1136/bmjopen-2021-052568.
2
Analysis of Risk Factors for Perioperative Acute Kidney Injury and Management Strategies.围手术期急性肾损伤的危险因素分析及管理策略
Front Med (Lausanne). 2021 Dec 24;8:751793. doi: 10.3389/fmed.2021.751793. eCollection 2021.
3
Anemia is associated with increased risk of contrast‑induced acute kidney injury: A Systematic Review and Meta-analysis.
贫血与对比剂诱导的急性肾损伤风险增加相关:系统评价和荟萃分析。
Bioengineered. 2021 Dec;12(1):648-661. doi: 10.1080/21655979.2021.1883887.
4
The conundrum of contrast-induced acute kidney injury.对比剂诱导的急性肾损伤难题。
J Thorac Dis. 2020 Apr;12(4):1721-1727. doi: 10.21037/jtd.2019.12.88.
5
Validation of pre-operative risk scores of contrast-induced acute kidney injury in a Chinese cohort.中国队列中对比剂诱导的急性肾损伤术前风险评分的验证
BMC Nephrol. 2020 Feb 10;21(1):45. doi: 10.1186/s12882-020-1700-8.
6
Rapamycin attenuates mitochondrial injury and renal tubular cell apoptosis in experimental contrast-induced acute kidney injury in rats.雷帕霉素减轻实验性对比剂诱导急性肾损伤大鼠的线粒体损伤和肾小管细胞凋亡。
Biosci Rep. 2018 Nov 20;38(6). doi: 10.1042/BSR20180876. Print 2018 Dec 21.
7
Recent advances in Chinese medicine for contrast-induced nephropathy.中药治疗对比剂肾病的最新进展。
Chin J Integr Med. 2018 Jan;24(1):6-9. doi: 10.1007/s11655-017-2906-x. Epub 2017 Oct 6.
8
Contrast-induced acute kidney injury: A review of practical points.对比剂诱导的急性肾损伤:实用要点综述
World J Nephrol. 2017 May 6;6(3):86-99. doi: 10.5527/wjn.v6.i3.86.
9
Contrast Circulation Time to Assess Right Ventricular Dysfunction in Pulmonary Embolism: A Retrospective Pilot Study.对比循环时间评估肺栓塞中的右心室功能障碍:一项回顾性初步研究
PLoS One. 2016 Aug 23;11(8):e0159674. doi: 10.1371/journal.pone.0159674. eCollection 2016.
10
Utilizing electronic health records to predict acute kidney injury risk and outcomes: workgroup statements from the 15(th) ADQI Consensus Conference.利用电子健康记录预测急性肾损伤风险及预后:第15届急性透析质量倡议(ADQI)共识会议工作组声明
Can J Kidney Health Dis. 2016 Feb 26;3:11. doi: 10.1186/s40697-016-0099-4. eCollection 2016.